Hca Holdings Stock News

HCA Healthcare (HCA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

This report looks at a Focus List Long stock that outperformed in 2021 and is positioned to outperform again in 2022.

HCA Healthcare's (HCA) fourth-quarter earnings are likely to have gained from rising admissions and higher revenues.

It's not too late to get in on these market-beating companies.

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

HCA (HCA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast: What: HCA Healthcare, Inc. 4Q Earnings Release Call When: Thursday, January 27, 2022 at 9:00 am cen

HCA Healthcare's (HCA) West Florida Division opens Hospital for Endocrine Surgery to boost portfolio and establish further dominance in the state.

Truist raised the price target on HCA Healthcare Inc (NYSE: HCA ) to $310 (implying 16% upside) from $290 and kept a Buy rating as part of a broader research note on Healthcare Services. Analyst David MacDonald is positive on several names in the group thanks to their "sound fundamentals, brisk core demand drivers, a relatively benign regulatory backdrop, and the ongoing move towards value-based care." MacDonald adds that strong free cash flow Full story available on Benzinga.com

HCA Healthcare Inc (HCA) shares closed today at 1.2% below its 52 week high of $263.40, giving the company a market cap of $80B. The stock is currently up 1.3% year-to-date, up 60.4% over the past 12 months, and up 249.5% over the past five years. This week, the Dow Jones Industrial Average rose 1.1%, and the S&P 500 rose 0.1%. Trading Activity Trading volume this week was 67.3% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.0. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -15.7% The company's stock price performance over the past 12 months lags the peer average by -6.6% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 55.9% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

The acquisition of MD Now adds 59 Florida urgent care clinics to HCA Healthcare's (HCA) portfolio.

Analysts have provided the following ratings for HCA Healthcare (NYSE: HCA ) within the last quarter:

Over the past three months, shares of HCA Healthcare (NYSE:HCA) increased by 11.90%. Before we understand the importance of debt, let us look at how

Shares of HCA Healthcare Inc. rallied 2.44% to $260.27 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow